Skip to main content

Published locations for ASH: Carfilzomib doubles progression free survival in head-to-head trial with bortezomib

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. ASH: Carfilzomib doubles progression free survival in head-to-head trial with bortezomib

User login

  • Reset your password
  • /content/ash-carfilzomib-doubles-progression-free-survival-head-head-trial-bortezomib
  • /hematologynews/article/104918/multiple-myeloma/ash-carfilzomib-doubles-progression-free-survival
  • /internalmedicinenews/article/104918/multiple-myeloma/ash-carfilzomib-doubles-progression-free
  • /oncologypractice/article/104918/multiple-myeloma/ash-carfilzomib-doubles-progression-free-survival
  • /hematology-oncology/article/104918/multiple-myeloma/ash-carfilzomib-doubles-progression-free
  • /internalmedicine/article/104918/multiple-myeloma/ash-carfilzomib-doubles-progression-free-survival